Pyruvate Kinase Deficiency Market Projected to Reach USD 1.99 Billion by 2035
The global pyruvate kinase (PK) deficiency market is experiencing notable growth, driven by advancements in treatment options, increased awareness of rare genetic disorders, and improvements in diagnostic technologies. PK deficiency is a rare genetic disorder that affects red blood cells, leading to hemolytic anemia. As healthcare systems prioritize rare disease research and patient advocacy...
0 التعليقات 0 المشاركات 6 مشاهدة 0 معاينة